DFIM
ICPT

Detwiler Fenton Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Detwiler Fenton Investment Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,405
Closed -$396K – 90
2015
Q1 		$396K Sell
1,405
-87
-6% -$18.8K 0.42% 36
2014
Q4 		$233K Sell
1,492
-103
-6% -$19K 0.26% 63
2014
Q3 		$378K Buy
1,595
+584
+58% +$149K 0.36% 41
2014
Q2 		$239K Buy
1,011
+183
+22% +$48.2K 0.19% 92
2014
Q1 		$273K Buy
+828
New +$279K 0.24% 76

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Detwiler Fenton Investment Management's ICPT Position: Q2 2015 in Review

Detwiler Fenton Investment Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2015, closing a stake of 1,405 shares — an estimated $396K sold.

Detwiler Fenton Investment Management first reported a position in ICPT in Q1 2014 and held it in 5 quarters. The position peaked at $396K in Q1 2015. 191 funds tracked by Wall St. Rank hold ICPT as of Q2 2015.

  • Detwiler Fenton Investment Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Detwiler Fenton Investment Management sold 1,405 Intercept Pharmaceuticals, Inc. shares in Q2 2015, an estimated $396K.
  • Detwiler Fenton Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 5 quarters.
  • Detwiler Fenton Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $396K in Q1 2015.
  • 191 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2015.

Based on Detwiler Fenton Investment Management's 13F filing for Q2 2015, filed 29 Jul 2015.